1. Home
  2. CRIS vs DLPN Comparison

CRIS vs DLPN Comparison

Compare CRIS & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • DLPN
  • Stock Information
  • Founded
  • CRIS 2000
  • DLPN 1996
  • Country
  • CRIS United States
  • DLPN United States
  • Employees
  • CRIS N/A
  • DLPN N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • DLPN Other Consumer Services
  • Sector
  • CRIS Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • CRIS 13.5M
  • DLPN 11.4M
  • IPO Year
  • CRIS 2000
  • DLPN N/A
  • Fundamental
  • Price
  • CRIS $1.97
  • DLPN $1.05
  • Analyst Decision
  • CRIS Strong Buy
  • DLPN Strong Buy
  • Analyst Count
  • CRIS 3
  • DLPN 1
  • Target Price
  • CRIS $21.00
  • DLPN $5.00
  • AVG Volume (30 Days)
  • CRIS 106.4K
  • DLPN 16.5K
  • Earning Date
  • CRIS 05-06-2025
  • DLPN 05-13-2025
  • Dividend Yield
  • CRIS N/A
  • DLPN N/A
  • EPS Growth
  • CRIS N/A
  • DLPN N/A
  • EPS
  • CRIS N/A
  • DLPN N/A
  • Revenue
  • CRIS $11,202,000.00
  • DLPN $48,618,803.00
  • Revenue This Year
  • CRIS $2.62
  • DLPN $2.62
  • Revenue Next Year
  • CRIS $9.84
  • DLPN $22.65
  • P/E Ratio
  • CRIS N/A
  • DLPN N/A
  • Revenue Growth
  • CRIS 14.17
  • DLPN 0.31
  • 52 Week Low
  • CRIS $1.02
  • DLPN $0.75
  • 52 Week High
  • CRIS $16.93
  • DLPN $2.78
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 52.24
  • DLPN 48.39
  • Support Level
  • CRIS $1.06
  • DLPN $1.00
  • Resistance Level
  • CRIS $2.45
  • DLPN $1.16
  • Average True Range (ATR)
  • CRIS 0.30
  • DLPN 0.06
  • MACD
  • CRIS 0.02
  • DLPN -0.01
  • Stochastic Oscillator
  • CRIS 36.19
  • DLPN 25.00

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: